Clinical Trial Update: Antiplatelet Activity of Aspirin in Infants After Aortopulmonary and Cavopulmonary Shunts

View source ↗

Summary

A clinical trial evaluating the antiplatelet activity of aspirin in infants after aortopulmonary and cavopulmonary shunts has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: University of Utah | Conditions: Congenital Heart Disease | Status: COMPLETED